Transgene SA (EPA:TNG)
France flag France · Delayed Price · Currency is EUR
0.7140
+0.0030 (0.42%)
Aug 3, 2026, 12:42 PM CET

Transgene Revenue

In the year 2025, Transgene had annual revenue of 7.21M EUR with 13.49% growth. Transgene had revenue of 139.00K in the half year ending December 31, 2025.

Revenue
7.21M
Revenue Growth
+13.49%
P/S Ratio
27.01
Revenue / Employee
49.72K
Employees
145
Market Cap
194.73M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.21M857.00K13.49%
Dec 31, 20246.35M-1.55M-19.58%
Dec 31, 20237.90M-2.44M-23.63%
Dec 31, 202210.34M-7.07M-40.60%
Dec 31, 202117.41M7.50M75.62%
Dec 31, 20209.92M-3.82M-27.80%
Dec 31, 201913.73M-29.19M-68.00%
Dec 31, 201842.92M34.78M427.00%
Dec 31, 20178.14M-2.17M-21.02%
Dec 31, 201610.31M362.00K3.64%
Dec 31, 20159.95M-1.15M-10.36%
Dec 31, 201411.10M-4.64M-29.46%
Dec 31, 201315.74M2.67M20.47%
Dec 31, 201213.06M-1.39M-9.59%
Dec 31, 201114.45M334.00K2.37%
Dec 31, 201014.11M2.35M19.95%
Dec 31, 200911.77M-5.31M-31.09%
Dec 31, 200817.07M-10.97M-39.11%
Dec 31, 200728.04M22.49M405.59%
Dec 31, 20065.55M1.39M33.57%
Dec 31, 20054.15M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Valneva SE156.33M
Cellectis65.14M
Innate Pharma9.01M
Sensorion5.81M
MaaT Pharma4.52M
DBV Technologies4.41M
ABIONYX Pharma4.06M
Adocia3.85M
Revenue Rankings

Transgene News

More News